Race, age, and sex were predictors of survival in patients with SCC of the upper esophagus, highlighting the need to address disparities in esophageal SCC management.

“The current trial showed that overall survival was better with FLOT than with preoperative chemoradiotherapy among patients with resectable esophageal adenocarcinoma, including those with a ...

The following is a summary of “Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer,” published ...

Barrett's esophagus is a premalignant condition that predisposes to the development of esophageal adenocarcinoma. The carcinogenetic process of Barrett's mucosa progresses through increasing ...

Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for survival in patients with resectable esophageal squamous cell carcinoma (JCOG2305A).

1 Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China 2 Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical ...

Chemoimmunotherapy plus radiotherapy in advanced esophageal squamous-cell carcinoma. Pembro: pembrolizumab, mo: month. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...

Patients who traveled to high-volume centers for esophagectomy experienced better outcomes than those who sought treatment ...

Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis, and understanding the molecular mechanisms underlying its progression is crucial for developing ...